{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:56:58Z","timestamp":1785603418832,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07427-6","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:08:02Z","timestamp":1785557282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does macular telangiectasia type 2 influence the retinal microvasculature in diabetic retinopathy?"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4280-5718","authenticated-orcid":false,"given":"Merve","family":"Ozbek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metehan","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Burak","family":"Onaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Artunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"7427_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ajo.2005.08.063","volume":"141","author":"TY - Wong","year":"2006","unstructured":"Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, Klein BE, Sharrett AR, Shea S (2006) Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 141:446\u2013455. https:\/\/doi.org\/10.1016\/j.ajo.2005.08.063","journal-title":"Am J Ophthalmol"},{"key":"7427_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JW - Yau","year":"2012","unstructured":"Yau JW, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556\u2013564. https:\/\/doi.org\/10.2337\/dc11-1909","journal-title":"Diabetes Care"},{"key":"7427_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ceo.12696","volume":"44","author":"DS - Ting","year":"2016","unstructured":"Ting DS, Cheung GC, Wong TY (2016) Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges. Clin Exp Ophthalmol 44:260\u2013277. https:\/\/doi.org\/10.1111\/ceo.12696","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"7427_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2337\/diab.38.10.1231","volume":"38","author":"RF - Hamman","year":"1989","unstructured":"Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J (1989) Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes 38(10):1231\u20131237. https:\/\/doi.org\/10.2337\/diab.38.10.1231","journal-title":"Diabetes"},{"key":"7427_CR5","doi-asserted-by":"publisher","unstructured":"Nakai M, Iwami H, Fukuyama H, Gomi F (2021) Visualization of microaneurysms in macular telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation. Graefes Arch Clin Exp Ophthalmol 259(6):1513\u20131520. https:\/\/doi.org\/10.1007\/s00417-020-04953-9","DOI":"10.1007\/s00417-020-04953-9"},{"key":"7427_CR6","doi-asserted-by":"publisher","unstructured":"Chew EY, Peto T, Clemons TE, Sallo FB, Pauleikhoff D, Leung I, Jaffe GJ, Heeren TFC, Egan CA, Charbel Issa P, Balaskas K, Holz FG, Gaudric A, Bird AC, Friedlander M (2022) Macular telangiectasia type 2: a classification system using multimodal imaging MacTel project report number 10. Ophthalmol Sci 3(2):100261. https:\/\/doi.org\/10.1016\/j.xops.2022.100261","DOI":"10.1016\/j.xops.2022.100261"},{"key":"7427_CR7","doi-asserted-by":"publisher","unstructured":"Ntentakis DP, Ntentaki AM, Delavogia E, Sakuno G, Corr\u00eaa VSMC, Efstathiou NE, Aronow ME, Chew EY, Miller JW, Vavvas DG (2026) Clinical histopathology and pathogenesis of macular telangiectasia type 2. Prog Retin Eye Res 110:101401. https:\/\/doi.org\/10.1016\/j.preteyeres.2025.101401","DOI":"10.1016\/j.preteyeres.2025.101401"},{"key":"7427_CR8","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/IAE.0000000000003851","volume":"43","author":"L -Sauer","year":"2023","unstructured":"Sauer L, Vitale AS, Jacoby RS, Hart B, Bernstein PS (2023) Fluorescence lifetime imaging ophthalmoscopy in patients with macular telangiectasia type 2 with and without diabetes. Retina 43:1597\u20131607. https:\/\/doi.org\/10.1097\/IAE.0000000000003851","journal-title":"Retina"},{"key":"7427_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.oret.2021.01.002","volume":"5","author":"SHM -van Romunde","year":"2021","unstructured":"van Romunde SHM, van der Sommen CM, Martinez Ciriano JP, Vingerling JR, Yzer S (2021) Prevalence and severity of diabetic retinopathy in patients with macular telangiectasia type 2. Ophthalmol Retina 5:999\u20131004. https:\/\/doi.org\/10.1016\/j.oret.2021.01.002","journal-title":"Ophthalmol Retina"},{"key":"7427_CR10","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","volume":"117","author":"MB -Powner","year":"2010","unstructured":"Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, Fruttiger M (2010) Perifoveal M\u00fcller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 117:2407\u20132416. https:\/\/doi.org\/10.1016\/j.ophtha.2010.04.001","journal-title":"Ophthalmology"},{"key":"7427_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40942-023-00505-5","volume":"9","author":"L -Wu","year":"2023","unstructured":"Wu L (2023) Unraveling the mysteries of macular telangiectasia 2: the intersection of philanthropy, multimodal imaging and molecular genetics. Int J Retina Vitreous 9:69. https:\/\/doi.org\/10.1186\/s40942-023-00505-5","journal-title":"Int J Retina Vitreous"},{"key":"7427_CR12","doi-asserted-by":"publisher","unstructured":"Gan J, Huang M, Lan G, Liu L, Xu F (2020) High glucose induces the loss of retinal pericytes partly via NLRP3-caspase-1-GSDMD-mediated pyroptosis. Biomed Res Int 2020:4510628. https:\/\/doi.org\/10.1155\/2020\/4510628","DOI":"10.1155\/2020\/4510628"},{"key":"7427_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40942-017-0103-x","volume":"3","author":"M -Jhingan","year":"2017","unstructured":"Jhingan M, Marsonia K, Shukla D, Rosenfeld PJ, Chhablani J (2017) Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy. Int J Retina Vitreous 3:50. https:\/\/doi.org\/10.1186\/s40942-017-0103-x","journal-title":"Int J Retina Vitreous"},{"key":"7427_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","volume":"34","author":"P - Charbel Issa","year":"2013","unstructured":"Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TF, Peto T, Holz FG, Scholl HP (2013) Macular telangiectasia type 2. Prog Retin Eye Res 34:49\u201377. https:\/\/doi.org\/10.1016\/j.preteyeres.2012.11.002","journal-title":"Prog Retin Eye Res"},{"key":"7427_CR15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","volume":"48","author":"-American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care 48:S27\u2013S49. https:\/\/doi.org\/10.2337\/dc25-S002","journal-title":"Diabetes Care"},{"key":"7427_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP -Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL, Klein RE et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677\u20131682. https:\/\/doi.org\/10.1016\/S0161-6420(03)00475-5","journal-title":"Ophthalmology"},{"key":"7427_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/bjo-2023-325115","volume":"109","author":"AL -Amram","year":"2025","unstructured":"Amram AL, Whitmore SS, Wang C et al (2025) Progressive inner retinal neurodegeneration in non-proliferative macular telangiectasia type 2. Br J Ophthalmol 109:401\u2013407. https:\/\/doi.org\/10.1136\/bjo-2023-325115","journal-title":"Br J Ophthalmol"},{"key":"7427_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/IAE.0b013e31822091b0","volume":"32","author":"D -Shukla","year":"2012","unstructured":"Shukla D, Gupta SR, Neelakantan N, Tiwari S, Gupta S, Patwardhan AR, Soubhya TB (2012) Type 2 idiopathic macular telangiectasia. Retina 32:265\u2013274. https:\/\/doi.org\/10.1097\/IAE.0b013e31822091b0","journal-title":"Retina"},{"key":"7427_CR19","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/IAE.0000000000001697","volume":"38","author":"T -Peto","year":"2018","unstructured":"Peto T, Heeren TFC, Clemons TE, Sallo FB, Leung I, Chew EY, Bird AC (2018) Correlation of clinical and structural progression with visual acuity loss in macular telangiectasia type 2: MacTel Project Report 6. Retina 38:S8\u2013S13. https:\/\/doi.org\/10.1097\/IAE.0000000000001697","journal-title":"Retina"},{"issue":"11","key":"7427_CR20","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1136\/bjophthalmol-2011-301009","volume":"96","author":"S - Cherepanoff","year":"2012","unstructured":"Cherepanoff S, Killingsworth MC, Zhu M, Nolan T, Hunyor AP, Young SH, Hageman GS, Gillies MC (2012) Ultrastructural and clinical evidence of subretinal debris accumulation in type 2 macular telangiectasia. Br J Ophthalmol 96(11):1404\u20131409. https:\/\/doi.org\/10.1136\/bjophthalmol-2011-301009","journal-title":"Br J Ophthalmol"},{"key":"7427_CR21","doi-asserted-by":"crossref","unstructured":"Powner MB, Woods SM, Zhu M, Gillies MC, Bernstein PS, Hageman GS, Comer GM, Egan C, Fruttiger M (2018) Fundus-wide subretinal and pigment epithelial abnormalities in macular telangiectasia type 2. Retina (Philadelphia, Pa.) 38(Suppl 1):S105\u2013S113","DOI":"10.1097\/IAE.0000000000001860"},{"issue":"6","key":"7427_CR22","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4103\/IJO.IJO_962_24","volume":"73","author":"V - Zare Hosseinabadi","year":"2025","unstructured":"Zare Hosseinabadi V, Abdi F, Parvin S, Hemmati S, Chaibakhsh S (2025) OCT angiography findings in type 2 macular telangiectasia: A meta-analysis. Indian J Ophthalmol 73(6):816\u2013821. https:\/\/doi.org\/10.4103\/IJO.IJO_962_24","journal-title":"Indian J Ophthalmol"},{"key":"7427_CR23","doi-asserted-by":"publisher","unstructured":"Busza AM, Lyons CE, Hamzeh N, Mohammadi SS, Gill MK (2026) Optical coherence tomography angiography in pediatric and adult populations: a comprehensive review. Surv Ophthalmol S0039\u201362572600042\u20131. (Advance online publication). https:\/\/doi.org\/10.1016\/j.survophthal.2026.03.009","DOI":"10.1016\/j.survophthal.2026.03.009"},{"key":"7427_CR24","doi-asserted-by":"publisher","first-page":"107856","DOI":"10.1016\/j.exer.2019.107856","volume":"189","author":"F - G\u00f3mez-Ulla","year":"2019","unstructured":"G\u00f3mez-Ulla F, Cutrin P, Santos P, Fernandez M, Abraldes M, Abalo-Lojo JM, Gonzalez F (2019) Age and gender influence on foveal avascular zone in healthy eyes. Exp Eye Res 189:107856. https:\/\/doi.org\/10.1016\/j.exer.2019.107856","journal-title":"Exp Eye Res"},{"issue":"4","key":"7427_CR25","doi-asserted-by":"publisher","first-page":"e0232255","DOI":"10.1371\/journal.pone.0232255","volume":"15","author":"YG - Park","year":"2020","unstructured":"Park YG, Park YH (2020) Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography. PLoS ONE 15(4):e0232255. https:\/\/doi.org\/10.1371\/journal.pone.0232255","journal-title":"PLoS ONE"},{"key":"7427_CR26","first-page":"804","volume":"19","author":"Y -Jiang","year":"2013","unstructured":"Jiang Y, Pagadala J, Miller D, Steinle JJ (2013) Reduced insulin receptor signaling in retinal M\u00fcller cells cultured in high glucose. Mol Vis 19:804\u2013811","journal-title":"Mol Vis"},{"key":"7427_CR27","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.2337\/db07-1520","volume":"57","author":"JV -Busik","year":"2008","unstructured":"Busik JV, Mohr S, Grant MB (2008) Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes 57:1952\u20131965. https:\/\/doi.org\/10.2337\/db07-1520","journal-title":"Diabetes"},{"issue":"2","key":"7427_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/IJO.IJO_784_25","volume":"74","author":"E - Osmanl\u0131","year":"2026","unstructured":"Osmanl\u0131 E, S\u00fcl S, Kaderli A, Kaderli ST, T\u00fcrk\u00e7\u00fc \u00dc (2026) M\u00fcller cell markers in aqueous humor of patients with type-2 macular telangiectasia. Indian J Ophthalmol 74(2):274\u2013278. https:\/\/doi.org\/10.4103\/IJO.IJO_784_25","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"7427_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","volume":"126","author":"EY - Chew","year":"2019","unstructured":"Chew EY, Clemons TE, Jaffe GJ, Johnson CA, Farsiu S, Lad EM, Guymer R, Rosenfeld P, Hubschman JP, Constable I, Wiley H, Singerman LJ, Gillies M, Comer G, Blodi B, Eliott D, Yan J, Bird A, Friedlander M (2019) Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial. Ophthalmology 126(4):540\u2013549. https:\/\/doi.org\/10.1016\/j.ophtha.2018.09.041. & Macular Telangiectasia Type 2-Phase 2 CNTF Research Group","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07427-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07427-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:02:37Z","timestamp":1785600157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07427-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":29,"alternative-id":["7427"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07427-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee. All authors adhered to the tenets of the Declaration of Helsinki. Written informed consent was provided from all participants enrolled in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}